Center for Cellular Therapy

At MUSC, the Center for Cellular Therapy (CCT) is an FDA registered cGMP level facility that meets the most rigorous standards in the aspect of processing of cells.

Mission

Our mission is to provide a leading-edge cellular therapy program to support the growth of innovative cellular therapy products at MUSC.

Vision

Our vision is to be a top-tiered center for cellular therapy with well-funded and top-ranking translational research programs bridging the gap between basic science and its clinical practice.

 

Overview

Our experienced team is available to provide services to investigators to:

• produce expanded cell-therapy and gene-therapy based biotherapeutic products for Phase I and II clinical studies employing current cGMP standards as required by federal regulations
• serve as a regulatory resource to MUSC in the preparation of cell and gene-therapy based INDs
• facilitate clinical development of novel cellular therapies

The Center for Cellular Therapy is continuously striving to push forward the boundaries of medicine, both at MUSC and nationally. We have the capacity to partner with MUSC investigators and outside biotech and pharmaceutical companies to manufacture cellular therapy products. We have clinicians working side-by-side with scientists, manufacturing staff and QA staff in our state-of-the art clean cell facility. And, we have assembled an extraordinary panel of advisors across many disciplines to aid in fulfilling our mission. Our capabilities range from immunomonitoring of patient samples to manufacturing of cellular products for immunotherapy.

Meet the Team

Meet our team of highly trained and dedicated resarchers and staff with expertise in all aspects of cellular therapy and cGMP phase I/II clinical trials.

Learn More About Our Facility 

At MUSC, the Center for Cellular Therapy (CCT) is an FDA registered cGMP level facility that meets the most rigorous standards in the aspect of processing of cells.

Our capabilities range from immunomonitoring of patient samples to manufacturing of cellular products for immunotherapy. Read more about our Facility. 

Resources at a Glance: 

• Reporting to regulatory agencies, sponsors, and IRB's of record.
• Preparation of standard-of-care cell products for cell therapy.
• Cell products for experimental IND-based cell therapy.
• Full-spectrum service from minimally manipulated to extensively cultured cells.
• Quality management, including quality assurance, quality control, and quality oversight committee.
• Responsive team that develops competency in all cell manipulations, including purification, culture and cytokine expansion, antigen exposure, cell differentiation protocols, and gene transfer.
• Comprehensive support--starting with IND preparation and regulatory guidance to development of Standard Operating Procedures and product delivery reimbursed by users.